Evaluation of sedation level by using SedLine during intravenous sedation for dental treatment

Evaluation of sedation level by using SedLine during intravenous sedation for dental treatment - Evaluation of sedation level by using SedLine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042451

Enrollment

Registered

2020-11-16

Start date

2020-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, periodontal disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients whose age is over 20 years. 2)Patients whose American Society of Anesthesiology physical state(ASA PS) is 1 or 2.

Exclusion criteria

Exclusion criteria: 1)Patients who needed management by deep sedation. 2)Patients who taking centrally acting drugs, such as anti-epileptic drugs and/or antipsychotic drugs. 3)Patients who are contraindicated for the use of midazolam or propofol. 4)Patients who are judged to be inappropriate for study participation.

Design outcomes

Primary

Measure	Time frame
Patient State Index at the start of dental treatment.	—

Secondary

Measure	Time frame
1)Average Patient State Index during dental treatment. 2)The estimated propofol concentration in target controlled infusion at the start of dental treatment. 3)Blood pressure, heart rate, and oxygen saturation during sedation. 4)Total amount of midazolam and propofol for sedation. 5)Amnesia during dental treatment. 6)Satisfaction with sedation.	—

Countries

Japan

Contacts

Public ContactHitoshi Higuchi

Okayama University Hospital Department of Dental Anesthesiology

higuti@md.okayama-u.ac.jp086-235-6721

Outcome results